Related Experiment Video
Updated: Aug 30, 2026
09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Application of rhenium-188 HEDP in bone metastases therapy
Justyna Scheffler1, Mirosława Derejko, Tomasz Bandurski
1Department of Nuclear Medicine, Medical University, Gdańsk, Poland. jscheffler@wp.pl
Nuclear Medicine Review. Central & Eastern Europe
|November 6, 2003
Abstract:
Radionuclide bone metastases therapy is a major achievement of nuclear medicine. Development of less radiotoxic and more effective radiopharmaceuticals is therefore a challenge for radiopharmacists and industry. This paper reviews the application of rhenium-188 HEDP as a reactor- or generator-produced nuclide for bone metastases therapy.
